Efficacy and Safety of Ustekinumab in Asian Patients with Moderately to Severely Active Ulcerative Colitis: A Subpopulation Analysis of UNIFI Long-Term Extension through 4 Years.

Kim HJ, Motoya S, Suzuki Y, Ohnishi Y, Marano CW, Imai Y, Wahking B, Zhuo J, Kawamura S, Hisamatsu T

Open source

DOI
10.1159/000549914
Published
2026 Jan-Dec
Container
Inflammatory intestinal diseases
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000549914,
  title = {Efficacy and Safety of Ustekinumab in Asian Patients with Moderately to Severely Active Ulcerative Colitis: A Subpopulation Analysis of UNIFI Long-Term Extension through 4 Years.},
  author = {Kim HJ and Motoya S and Suzuki Y and Ohnishi Y and Marano CW and Imai Y and Wahking B and Zhuo J and Kawamura S and Hisamatsu T},
  year = {2026},
  journal = {Inflammatory intestinal diseases},
  doi = {10.1159/000549914},
  url = {https://doi.org/10.1159/000549914}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Ustekinumab in Asian Patients with Moderately to Severely Active Ulcerative Colitis: A Subpopulation Analysis of UNIFI Long-Term Extension through 4 Years.
AU  - Kim HJ
AU  - Motoya S
AU  - Suzuki Y
AU  - Ohnishi Y
AU  - Marano CW
AU  - Imai Y
AU  - Wahking B
AU  - Zhuo J
AU  - Kawamura S
AU  - Hisamatsu T
PY  - 2026
JO  - Inflammatory intestinal diseases
DO  - 10.1159/000549914
UR  - https://doi.org/10.1159/000549914
ER  - 

APA

HJ, K., S, M., Y, S., Y, O., CW, M., Y, I., B, W., J, Z., S, K., & T, H. (2026). Efficacy and Safety of Ustekinumab in Asian Patients with Moderately to Severely Active Ulcerative Colitis: A Subpopulation Analysis of UNIFI Long-Term Extension through 4 Years.. Inflammatory intestinal diseases. https://doi.org/10.1159/000549914

Source records